Terms: = Kidney tumors AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
108 results:
1. Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation.
Gao W; Zhou J; Huang J; Zhang Z; Chen W; Zhang R; Kang T; Liao D; Zhong L
Cancer Lett; 2024 Apr; 586():216708. PubMed ID: 38336287
[TBL] [Abstract] [Full Text] [Related]
2. Targeting myc induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma.
Sainero-Alcolado L; Garde-Lapido E; Snaebjörnsson MT; Schoch S; Stevens I; Ruiz-Pérez MV; Dyrager C; Pelechano V; Axelson H; Schulze A; Arsenian-Henriksson M
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2310479121. PubMed ID: 38335255
[TBL] [Abstract] [Full Text] [Related]
3. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
Masel R; Roche ME; Martinez-Outschoorn U
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
[TBL] [Abstract] [Full Text] [Related]
4.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract] [Full Text] [Related]
5. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
6. PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma.
Peng S; Wang Z; Tang P; Wang S; Huang Y; Xie Q; Wang Y; Tan X; Tang T; Yan X; Xu J; Lan W; Wang L; Zhang D; Wang B; Pan T; Qin J; Jiang J; Liu Q
Sci Adv; 2023 Aug; 9(31):eadf3566. PubMed ID: 37531433
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of cmyc-MAX transcription factors hetero-dimerization with structurally engineered omomyc to downregulate oncogenic pathways in renal carcinoma.
Li W; Bano F; Khan A; Wei DQ; Alshammari A; Xu B; Wang Y
Comput Biol Med; 2023 Sep; 164():107257. PubMed ID: 37527610
[TBL] [Abstract] [Full Text] [Related]
8. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Yuan H; Qin X; Yang Q; Liu L; Fang Z; Fan Y; Xu D
Biol Sex Differ; 2023 Jul; 14(1):46. PubMed ID: 37434223
[TBL] [Abstract] [Full Text] [Related]
9. ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma.
Wang H; Zhao J; He H; Xie X; Dai J; Xu D; Huang X
Biochem Biophys Res Commun; 2023 Sep; 671():255-262. PubMed ID: 37307709
[TBL] [Abstract] [Full Text] [Related]
10. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
11. HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis.
Yin L; Li W; Chen X; Wang R; Zhang T; Meng J; Li Z; Xu L; Yin R; Cheng B; Yang H
Adv Sci (Weinh); 2023 Jun; 10(17):e2206955. PubMed ID: 37085921
[TBL] [Abstract] [Full Text] [Related]
12. 3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-myc.
Pan JM; Li JC; Yang C; Xiao WF; Li QS; Luo XH; Zhang XD
Anticancer Agents Med Chem; 2023; 23(12):1421-1428. PubMed ID: 37038711
[TBL] [Abstract] [Full Text] [Related]
13. PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter.
Zhu M; Zhang RN; Zhang H; Qu CB; Zhang XC; Ren LX; Yang Z; Gu JF
Epigenetics Chromatin; 2023 Mar; 16(1):9. PubMed ID: 36890610
[TBL] [Abstract] [Full Text] [Related]
14. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
15. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Ma Y; Joyce A; Brandenburg O; Saatchi F; Stevens C; Toffessi Tcheuyap V; Christie A; Do QN; Fatunde O; Macchiaroli A; Wong SC; Woolford L; Yousuf Q; Miyata J; Carrillo D; Onabolu O; McKenzie T; Mishra A; Hardy T; He W; Li D; Ivanishev A; Zhang Q; Pedrosa I; Kapur P; Schluep T; Kanner SB; Hamilton J; Brugarolas J
Clin Cancer Res; 2022 Dec; 28(24):5405-5418. PubMed ID: 36190432
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.
Pahwa R; Dubhashi J; Singh A; Jailwala P; Lobanov A; Thomas CJ; Ceribelli M; Wilson K; Ricketts CJ; Vocke CD; Wells C; Bottaro DP; Linehan WM; Neckers L; Srinivasan R
J Exp Clin Cancer Res; 2022 Jun; 41(1):208. PubMed ID: 35754026
[TBL] [Abstract] [Full Text] [Related]
17. Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome
Jiang A; Meng J; Gong W; Zhang Z; Gan X; Wang J; Wu Z; Liu B; Qu L; Wang L
Front Immunol; 2022; 13():842069. PubMed ID: 35281041
[TBL] [Abstract] [Full Text] [Related]
18. Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma.
Kotulak-Chrzaszcz A; Rybarczyk A; Klacz J; Matuszewski M; Kmiec Z; Wierzbicki PM
Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35266008
[TBL] [Abstract] [Full Text] [Related]
19. CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop.
Gong LJ; Wang XY; Yao XD; Wu X; Gu WY
Cell Death Dis; 2021 Nov; 12(11):1081. PubMed ID: 34775467
[TBL] [Abstract] [Full Text] [Related]
20. Visualization of endogenous p27 and Ki67 reveals the importance of a c-myc-driven metabolic switch in promoting survival of quiescent cancer cells.
La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L
Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389
[No Abstract] [Full Text] [Related]
[Next]
